tiprankstipranks
Advertisement
Advertisement

MNOV Stock Latest News

Super Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
The FlySuper Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
12d ago
BIP
BOX
Maxim resumes MediciNova at Buy on potential value-driving data events this year
PremiumThe Fly
Maxim resumes MediciNova at Buy on potential value-driving data events this year
12d ago
MNOV
MediciNova resumed with a Buy at Maxim
PremiumThe Fly
MediciNova resumed with a Buy at Maxim
12d ago
MNOV
MediciNova initiated with a Buy at H.C. Wainwright
PremiumThe Fly
MediciNova initiated with a Buy at H.C. Wainwright
19d ago
MNOV
MediciNova management to meet with Maxim
PremiumThe Fly
MediciNova management to meet with Maxim
1M ago
MNOV
MediciNova issues letter to shareholders
PremiumThe FlyMediciNova issues letter to shareholders
3M ago
MNOV
MediciNova initiated with a Buy at Lucid Capital
Premium
The Fly
MediciNova initiated with a Buy at Lucid Capital
3M ago
MNOV
MediciNova Establishes Flexible At-The-Market Equity Program
Premium
Company Announcements
MediciNova Establishes Flexible At-The-Market Equity Program
3M ago
8K
MNOV
MediciNova completes patient enrollment in neuropathy trial of MN-166
PremiumThe Fly
MediciNova completes patient enrollment in neuropathy trial of MN-166
4M ago
MNOV
MediciNova files $300M mixed securities shelf
PremiumThe Fly
MediciNova files $300M mixed securities shelf
4M ago
MNOV
MediciNova names Dr. Christopher Breder as Clinical and Regulatory Advisor
PremiumThe Fly
MediciNova names Dr. Christopher Breder as Clinical and Regulatory Advisor
5M ago
MNOV
MediciNova completes patient enrollment in MN-001-NATG-202 trial
PremiumThe Fly
MediciNova completes patient enrollment in MN-001-NATG-202 trial
5M ago
MNOV
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
PremiumThe FlyMediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
5M ago
MNOV
MediciNova completes patient enrollment in COMBAT-ALS Phase 2b/3 trial
Premium
The Fly
MediciNova completes patient enrollment in COMBAT-ALS Phase 2b/3 trial
6M ago
MNOV
MediciNova provides update on SEPA, COMBAT-ALS trial enrollment
Premium
The Fly
MediciNova provides update on SEPA, COMBAT-ALS trial enrollment
7M ago
MNOV
MediciNova achieves enrollment in COMBAT-ALS clinical trial
PremiumThe Fly
MediciNova achieves enrollment in COMBAT-ALS clinical trial
7M ago
MNOV
MediciNova files to sell 25M shares of common stock for holders
PremiumThe Fly
MediciNova files to sell 25M shares of common stock for holders
7M ago
MNOV
MediciNova Secures $30 Million Equity Purchase Agreement
PremiumCompany Announcements
MediciNova Secures $30 Million Equity Purchase Agreement
8M ago
8K
MNOV
MediciNova enters $30M equity purchase agreement
PremiumThe Fly
MediciNova enters $30M equity purchase agreement
8M ago
MNOV
MediciNova provides enrollment update for two key ongoing clinical trials
PremiumThe FlyMediciNova provides enrollment update for two key ongoing clinical trials
8M ago
MNOV
Medicinova Announces Results of Annual Stockholders Meeting
Premium
Company Announcements
Medicinova Announces Results of Annual Stockholders Meeting
10M ago
8K
MNOV
MediciNova price target lowered to $5 from $6 at B. Riley
Premium
The Fly
MediciNova price target lowered to $5 from $6 at B. Riley
10M ago
MNOV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >